HCW Biologics just had its wildest trading day in months—shares soared over 60% after news dropped about their next-gen cancer drug. They’re claiming it could outdo Merck’s Keytruda by not just unleashing the immune system, but also helping immune cells break into tough tumors. Early lab results look promising, and the hype is real: retail traders are piling in, and some are already cashing out big. Could this be the next blockbuster? #Health #BodyHealth #stocks